Home
About
Team
Portfolio
News
Contact Us
2021-07-21
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
Imago a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms, announced IPO
2021-05-07
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
Singular, which is developing novel next generation sequencing and multiomics technologies, filed with the SEC to raise up to $100M in an IPO
2019-11-28
Pharmaron Announced 117 Million H-Shares on the Hong Kong Stock Exchange
Pharmaron announced today that 117 million H-shares are listed on the Main Board of The Stock Exchange of Hong Kong
2019-01-28
Pharmaron Announces Listing of Initial Public Offering on Shenzhen Stock Exchange
Pharmaron announced today its initial public offering (IPO) on the Shenzhen Stock Exchange(Stock Code: 300759.SZ)
2018-09-14
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline
1
2
3
17 records in total